These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28150072)

  • 21. [Public GCP unit--experiences from the Aarhus University Hospital].
    Jørgensen A; Rønnow IL; Nexø E
    Ugeskr Laeger; 2003 Apr; 165(16):1667-9. PubMed ID: 12756826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol Deviations before and after Treatment with Intravenous Tissue Plasminogen Activator in Community Hospitals.
    Adelman EE; Scott PA; Skolarus LE; Fox AK; Frederiksen SM; Meurer WJ
    J Stroke Cerebrovasc Dis; 2016 Jan; 25(1):67-73. PubMed ID: 26419527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of Japanese clinical trials estimated from GCP audit findings.
    Saito K; Kodama Y; Ono S; Maida C; Fujimura A; Miyamoto E
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):415-20. PubMed ID: 18793583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive analysis of clinical development and regulatory submission promotion schemes for oncologic drugs as the Japanese national projects.
    Nagai S; Ozawa K
    Invest New Drugs; 2016 Dec; 34(6):777-791. PubMed ID: 27538583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the Study Characteristics Affecting Clinical Trial Quality Using the Protocol Deviations Leading to Exclusion of Subjects From the Per Protocol Set Data in Studies for New Drug Application: A Retrospective Analysis.
    Kohara N; Kaneko M; Narukawa M
    Ther Innov Regul Sci; 2019 Jan; 53(1):45-51. PubMed ID: 29714591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ottawa Statement. International registration of protocol information and results from human trials of health related interventions.
    Fedorowicz Z; Al-Hajeri AA
    Saudi Med J; 2005 Dec; 26(12):1860-1. PubMed ID: 16380762
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality of Japanese clinical trials estimated from good clinical practice audit findings.
    Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
    Am J Ther; 2006; 13(2):127-33. PubMed ID: 16645429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Globalization of clinical trials].
    Akaza H; Fukuoka M; Ohtsu A; Usami M; Ikeda T; Aiba K; Isonishi S; Ohashi Y; Saijo N; Sone S; Tsukagoshi S; Tsuruo T; Kato M; Mikami O; Dong RP; von Euler M; Blackledge G; Stribling D
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):555-65. PubMed ID: 12722692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inconsistent Reporting Between Meta-analysis Protocol and Publication - A Cross-Sectional Study.
    Delgado AF; Delgado AF
    Anticancer Res; 2017 Sep; 37(9):5101-5107. PubMed ID: 28870940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.
    Veney JE; Kory WP; Barnsley JM; Kaluzny AD
    J Med Syst; 1991 Dec; 15(5-6):335-44. PubMed ID: 1812186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SPIRIT 2013 statement--defining standard protocol items for trials.
    Agha RA; Altman DG; Rosin D
    Int J Surg; 2015 Jan; 13():288-291. PubMed ID: 25498499
    [No Abstract]   [Full Text] [Related]  

  • 32. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
    Tobisu K
    Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation of elderly patients in registration trials for oncology drug applications in Japan.
    Yonemori K; Hirakawa A; Komiyama N; Kouno T; Ando M; Fujiwara Y; Urano T; Akagawa H; Maruyama H; Toyoshima S
    Ann Oncol; 2010 Oct; 21(10):2112-2118. PubMed ID: 20332138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trial registration records, updates, and protocols.
    Askie L
    Lancet; 2016 Jul; 388(10042):341-342. PubMed ID: 27477162
    [No Abstract]   [Full Text] [Related]  

  • 35. The Life Cycle and Management of Protocol Deviations.
    Mehra M; Kurpanek K; Petrizzo M; Brenner S; McCracken Y; Katz T; Gurian M
    Ther Innov Regul Sci; 2014 Nov; 48(6):762-777. PubMed ID: 30227474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing oncology research protocols.
    Lunik MC
    Top Hosp Pharm Manage; 1994 Jul; 14(2):11-21. PubMed ID: 10136201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the Relationship Between Protocol Adherence, Study Complexity and Personnel in Surgical Clinical Trials.
    Akpoviroro O; Castagne-Charlotin M; Joyce NP; Malikova MA
    Ther Innov Regul Sci; 2023 Jul; 57(4):619-628. PubMed ID: 36930415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of and errors in randomized multicenter trials. A review of 230 clinical trials.
    Reizenstein P; Delgado M; Gastiaburu J; Lomme L; Ogier C; Pals H; Schellekens J; Whittaker J; Mathé G
    Biomed Pharmacother; 1983; 37(1):14-24. PubMed ID: 6616027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocol development, treatment fidelity, adherence to treatment, and quality control.
    Persch AC; Page SJ
    Am J Occup Ther; 2013; 67(2):146-53. PubMed ID: 23433268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring clinical trials.
    Sharples K; Fleming TR; MacMahon S; Moore A; Reid I; Scoggins B
    N Z Med J; 1998 Aug; 111(1072):322-5. PubMed ID: 9765633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.